Is primary angioplasty feasible or will we provide a two-tier service?

10 Simes JR, Weaver DW, Ellis SG, Grines CL. Overview of the randomised trials of primary PTCA and thrombolysis in acute myocardial infarction [abstract]. Circulation 1997;94(suppl):I33 1. 11 ISIS-3 collaboration group. A randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction. Lancet 1992;339:753-70. 12 The GUSTO lIb Investigators. A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes. N Englj7Med 1966;335:775-82. 13 RITA trial participants. Coronary angioplasty versus coronary artery bypass surgery: the randomised intervention treatment of angina (RITA) trial. Lancet 1993;341: 573-80. 14 TIMI IHB investigators. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB trial. Thrombolysis in myocardial ischemia. Circulation 1994;89: 1545-56. 15 Every NR, Parsons IS, Haltky M, et al. For the MITI investigators. A comparison of thrombolytic therapy with primary coronary angioplasty for acute myocardial infarction. NEnglJMed 1996;335:1253-60. 16 de Boer MJ, van Hout BA, Liem AL, Suryapranata H, Hoomtje JCA, Zijlstra F. A cost-effective analysis of primary coronary angioplasty versus thrombolysis for acute myocardial infarction. Am J Cardiol 1995;76:830-3. 17 Stone GW, Grines CL, Rothbaum D, et al. Analysis of the relative costs and effectiveness of pimary angioplasty versus tissue-type plasminogen activator: the primary angioplasty in myocardial infarction (PAMI) trial. J Am Coll Cardiol 1997;29:901-7. 18 Zahn R, Vogt A, Neuhaus K-L, Schuster S, Senges J for the ALKK study group. Angioplasty in acute myocardial infarction in clinical practise: results in 4625 patients from the ALKK angioplasty registry [abstract]. JAm Coll Cardiol 1997;29(suppl A): 15A. 19 European Working Party. Streptokinase in recent myocardial infarction: a controlled multicentre trial. BMJ 197 1;3:325-3 1. 20 Yusuf S, Collins R, Peto R, et al. Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side effects from 33 randomised controlled trials. Eur HeartJ 1985;6:556-85. 21 Fibrinolytic Therapy Trialists' (FTF) Collaborative Group. Indication for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994;343:311-22. 22 ISIS-2 (Second International Study of Infarct Survival) collaboration group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17187 cases of acute myocardial infarction. Lancet 1988,ii: 349-60.